Terms: = Breast cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
548 results:
1. A second-generation eif4a RNA helicase inhibitor exploits translational reprogramming as a vulnerability in triple-negative breast cancer.
Cencic R; Im YK; Naineni SK; Moustafa-Kamal M; Jovanovic P; Sabourin V; Annis MG; Robert F; Schmeing TM; Koromilas A; Paquet M; Teodoro JG; Huang S; Siegel PM; Topisirovic I; Ursini-Siegel J; Pelletier J
Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2318093121. PubMed ID: 38232291
[TBL] [Abstract] [Full Text] [Related]
2. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
[TBL] [Abstract] [Full Text] [Related]
3. An update on rehabilitative treatment of shoulder disease after breast cancer care.
Ferrara PE; Gatto DM; Codazza S; Zordan P; Stefinlongo G; Ariani M; Coraci D; Ronconi G
Musculoskelet Surg; 2024 Mar; 108(1):31-45. PubMed ID: 38038901
[TBL] [Abstract] [Full Text] [Related]
4. Targeting eif4a triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Zhao N; Kabotyanski EB; Saltzman AB; Malovannaya A; Yuan X; Reineke LC; Lieu N; Gao Y; Pedroza DA; Calderon SJ; Smith AJ; Hamor C; Safari K; Savage S; Zhang B; Zhou J; Solis LM; Hilsenbeck SG; Fan C; Perou CM; Rosen JM
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37874652
[TBL] [Abstract] [Full Text] [Related]
5. Including the method of detection for breast cancer in the Surveillance, Epidemiology, and End Results database is long overdue.
Kopans DB; Sharpe RE; Eby PR
J Med Screen; 2024 Mar; 31(1):1-2. PubMed ID: 37624726
[TBL] [Abstract] [Full Text] [Related]
6. [Secular trends of age at menarche and age at menopause in women born since 1951 from a county of Shandong Province, China].
Wang XW; Mu YC; Guo ZY; Zhou YB; Zhang Y; Li HT; Liu JM
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):502-510. PubMed ID: 37291927
[TBL] [Abstract] [Full Text] [Related]
7. Optimal modeling of anti-breast cancer candidate drugs screening based on multi-model ensemble learning with imbalanced data.
Zhou J; Li X; Ma Y; Wu Z; Xie Z; Zhang Y; Wei Y
Math Biosci Eng; 2023 Jan; 20(3):5117-5134. PubMed ID: 36896538
[TBL] [Abstract] [Full Text] [Related]
8. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
[TBL] [Abstract] [Full Text] [Related]
9. eif4a/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative breast cancer Cell Model.
González-Ortiz A; Pulido-Capiz A; Castañeda-Sánchez CY; Ibarra-López E; Galindo-Hernández O; Calderón-Fernández MA; López-Cossio LY; Díaz-Molina R; Chimal-Vega B; Serafín-Higuera N; Córdova-Guerrero I; García-González V
Cells; 2022 Dec; 11(24):. PubMed ID: 36552834
[TBL] [Abstract] [Full Text] [Related]
10. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
11. Nomogram for predicting distant metastasis of male breast cancer: A SEER population-based study.
Wang D; Yang L; Yang Y; Chen M; Yang H
Medicine (Baltimore); 2022 Sep; 101(39):e30978. PubMed ID: 36181026
[TBL] [Abstract] [Full Text] [Related]
12. [Spatio-temporal trend of female breast cancer mortality in Shandong Province from 1970 to 2013].
Chu J; Lu ZL; Liu J; Fu ZT; Liu T; Dong J; Ren J; Chen XX; Guo XL; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 May; 56(5):609-613. PubMed ID: 35644975
[TBL] [Abstract] [Full Text] [Related]
13. Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis.
Davey MG; Cleere EF; O'Donnell JP; Gaisor S; Lowery AJ; Kerin MJ
Breast Cancer Res Treat; 2022 Jun; 193(3):535-544. PubMed ID: 35426541
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic breast cancer.
Li X; Beeghly-Fadiel A; Bhavnani SK; Tavana H; Rubinstein SM; Gyawali B; Riaz IB; Fernandes HD; Warner JL
JAMA Netw Open; 2022 Apr; 5(4):e224361. PubMed ID: 35416993
[TBL] [Abstract] [Full Text] [Related]
15. A retrospective validation of CanAssist breast in European early-stage breast cancer patient cohort.
Gunda A; Basavaraj C; Serkad V CP; Adinarayan M; Kolli R; Siraganahalli Eshwaraiah M; Saura C; Ruiz F; Gomez P; Peg V; Jimenez J; Sprung S; Fiegl H; Brunner C; Egle D; Bhattacharyya GS; Bakre MM
Breast; 2022 Jun; 63():1-8. PubMed ID: 35245746
[TBL] [Abstract] [Full Text] [Related]
16. Effect of post-diagnosis exercise on depression symptoms, physical functioning and mortality in breast cancer survivors: A systematic review and meta-analysis of randomized control trials.
Salam A; Woodman A; Chu A; Al-Jamea LH; Islam M; Sagher M; Sager M; Akhtar M
Cancer Epidemiol; 2022 Apr; 77():102111. PubMed ID: 35091272
[TBL] [Abstract] [Full Text] [Related]
17. Early-life exposures and age at thelarche in the Sister Study cohort.
Goldberg M; D'Aloisio AA; O'Brien KM; Zhao S; Sandler DP
Breast Cancer Res; 2021 Dec; 23(1):111. PubMed ID: 34895281
[TBL] [Abstract] [Full Text] [Related]
18. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.
Nagar H; Wietek N; Goodall RJ; Hughes W; Schmidt-Hansen M; Morrison J
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013021. PubMed ID: 34106467
[TBL] [Abstract] [Full Text] [Related]
19. A meta-analysis of the efficacy of vascularised lymph node transfer in reducing limb volume and cellulitis episodes in patients with cancer treatment-related lymphoedema.
Ward J; King I; Monroy-Iglesias M; Russell B; van Hemelrijck M; Ramsey K; Khan AA
Eur J Cancer; 2021 Jul; 151():233-244. PubMed ID: 34092349
[TBL] [Abstract] [Full Text] [Related]
20. Age as a risk factor for breast cancer-related lymphedema: a systematic review.
Guliyeva G; Huayllani MT; Boczar D; Avila FR; Lu X; Forte AJ
J Cancer Surviv; 2023 Feb; 17(1):246-253. PubMed ID: 33486706
[TBL] [Abstract] [Full Text] [Related]
[Next]
